# US 2022/0031787 A1 · Agent for preventing and/or treating neurodegenerative diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031787 A1
- Document ID: US20220031787A1
- Status: Published application
- Kind: A1
- Application number: 17/293,582
- Filed: 2019-11-12
- Published: 2022-02-03
- Earliest claimed: 2018-11-13
- Assignees: Green Tech Co., Ltd.; M.C.B.
- Applicants: Green Tech Co., Ltd.; McB.,Co.
- Inventors: Hachiro SUGIMOTO; Koki NAGASHIMA; Michiaki OKUDA; Yuki FUJITA
- Web page: https://patentgrep.com/patent/US20220031787A1

## CPC

- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 36/42: Cucurbitaceae (Cucumber family)
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The problems to be solved by the present invention are to provide a novel agent for preventing and/or treating a neurodegenerative disease, and a pharmaceutical composition comprising the agent for preventing and/or treating a neurodegenerative disease. The problems are solved by providing an agent for preventing and/or treating a neurodegenerative disease, the agent comprising as an active ingredient an extract of Momordica charantia var. pavel, and preferably the agent is for use in treatment or prevention of a disease selected from Alzheimer's disease, Parkinson's disease, Down syndrome, tauopathy (for example, argyrophilic grain dementia, senile dementia of neurofibrillary tangle type, progressive supranuclear palsy, degeneration of cerebral cortex or Pick disease), and dementia with lewy bodies.

## Claims

### Claim at position 1

1-7. (canceled)

### Claim 8

A method for preventing and/or treating a neurodegenerative disease, the method comprising administering to a subject an agent comprising as an active ingredient an extract of Momordica charantia var. pavel, wherein the extract is substantially free of quinine.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the extract of Momordica charantia var. pavel is an extract of leaves of Momordica charantia var. pavel.

### Claim 10 (depends on 8)

The method according to claim 8 for use in treatment or prevention of a disease selected from Alzheimer's disease, Parkinson's disease, Down syndrome, tauopathy, and dementia with lewy bodies.

### Claim 11

A method of using an extract of Momordica charantia var. pavel, wherein the extract is substantially free of quinine, which comprising administering an agent containing the extract to subject in need to prevent and/or treat a neurodegenerative disease.
